1-[(2S)-2-(cyclopropylmethoxy)propyl]-3-[1-methyl-5-(2-quinoxalin-6-ylethynyl)pyrazol-3-yl]urea | 1280213-00-4

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二氮杂萘
• 英文名称: 1-[(2S)-2-(cyclopropylmethoxy)propyl]-3-[1-methyl-5-(2-quinoxalin-6-ylethynyl)pyrazol-3-yl]urea
• CAS: 1280213-00-4
• 化学式: C₂₂H₂₄N₆O₂
• 分子量: 404.472
• InChiKey: WXUNMWNARWLTRA-HNNXBMFYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.9
• 重原子数：
  30
• 可旋转键数：
  8
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.36
• 拓扑面积：
  94
• 氢给体数：
  2
• 氢受体数：
  5

文献信息

• PYRAZOLE INHIBITORS OF PHOSPHATIDYLINOSITOL 3-KINASE
  申请人：Messersmith David

  公开号：US20110081316A1

  公开（公告）日：2011-04-07

  The present invention relates to compounds useful as inhibitors of PI3K, particularly of PI3Kγ. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders.

  本发明涉及作为PI3K抑制剂的化合物，特别是PI3Kγ的抑制剂。该发明还提供了包含这些化合物的药学上可接受的组合物，并提供了在治疗各种疾病、症状或障碍中使用这些组合物的方法。
• [EN] PYRAZOLE INHIBITORS OF PHOSPHATIDYLINOSITOL 3-KINASE<br/>[FR] PYRAZOLES INHIBITEURS DE PHOSPHATIDYLINOSITOL 3-KINASE
  申请人：VERTEX PHARMA

  公开号：WO2011041634A1

  公开（公告）日：2011-04-07

  The present invention relates to compounds useful as inhibitors of P13K, particularly of P13Kγ. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders.